pyrrolidonecarboxylic acid has been researched along with Liver Cirrhosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borro, P; Leone, S; Testino, G | 1 |
Farrell, G; George, J; Hou, JY; Leclercq, I; Pera, N; Phung, N | 1 |
Annoni, G; Arosio, B; Caputo, A; Contu, L; Tronci, MA | 1 |
3 other study(ies) available for pyrrolidonecarboxylic acid and Liver Cirrhosis
Article | Year |
---|---|
Liver Disease and Hepatocellular Carcinoma in Alcoholics: The Role of Anticraving Therapy.
Topics: Acamprosate; Alcohol Deterrents; Alcoholics; Alcoholism; Baclofen; Carcinoma, Hepatocellular; Drug Combinations; Humans; Liver Cirrhosis; Liver Neoplasms; Pyridoxine; Pyrrolidonecarboxylic Acid; Risk Factors; Taurine | 2016 |
Pro-oxidant-mediated hepatic fibrosis and effects of antioxidant intervention in murine dietary steatohepatitis.
Topics: Animals; Antioxidants; Choline; Cytokines; Diet; Gene Expression; Glutathione; Hepatic Stellate Cells; Hepatitis; Liver; Liver Cirrhosis; Male; Matrix Metalloproteinases; Methionine; Mice; Mice, Inbred C57BL; Pyrrolidonecarboxylic Acid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazolidines; Thiobarbituric Acid Reactive Substances; Time Factors; Tissue Inhibitor of Metalloproteinases; Vitamin E | 2009 |
Pyridoxol L,2-pyrrolidon-5 carboxylate prevents active fibroplasia in CCl4-treated rats.
Topics: Animals; Carbon Tetrachloride Poisoning; Drug Combinations; Female; Injections, Intraperitoneal; Liver Cirrhosis; Procollagen-Proline Dioxygenase; Pyridoxine; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains | 1992 |